378 related articles for article (PubMed ID: 10699346)
1. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
4. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients.
Kim DK; Kim JJ; Kim JH; Woo YM; Kim S; Yoon DW; Choi CS; Kim I; Park WJ; Lee N; Jung SB; Ahn BY; Nam SW; Yoon SM; Choi WJ
Vaccine; 2000 Dec; 19(9-10):1274-83. PubMed ID: 11137267
[TBL] [Abstract][Full Text] [Related]
6. Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans.
Lee N; Ahn B; Jung SB; Kim YG; Kim H; Park WJ
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):79-85. PubMed ID: 10617794
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
Matthews-Greer JM; Gilleland HE
J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
[TBL] [Abstract][Full Text] [Related]
8. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine.
Jang IJ; Kim IS; Park WJ; Yoo KS; Yim DS; Kim HK; Shin SG; Chang WH; Lee NG; Jung SB; Ahn DH; Cho YJ; Ahn BY; Lee Y; Kim YG; Nam SW; Kim HS
Vaccine; 1999 Jan; 17(2):158-68. PubMed ID: 9987150
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
Cripps AW; Peek K; Dunkley M; Vento K; Marjason JK; McIntyre ME; Sizer P; Croft D; Sedlak-Weinstein L
Infect Immun; 2006 Feb; 74(2):968-74. PubMed ID: 16428742
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against P. aeruginosa infections by large-scale affinity-purified human IgG specific to P. aeruginosa outer membrane proteins.
Lee NG; Jung SB; Ahn BY; Kim YG; Lee Y; Jeon YJ; Park WJ
Vaccine; 1999 Nov; 18(7-8):665-74. PubMed ID: 10547426
[TBL] [Abstract][Full Text] [Related]
11. Recombinant
Li P; Wang X; Sun X; Cimino J; Guan Z; Sun W
Infect Immun; 2021 Oct; 89(11):e0039621. PubMed ID: 34310892
[TBL] [Abstract][Full Text] [Related]
12. Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-protective against infection with heterologous immunotype strains of P. aeruginosa.
Lee NG; Ahn BY; Jung SB; Kim YG; Lee Y; Kim HS; Park WJ
FEMS Immunol Med Microbiol; 1999 Sep; 25(4):339-47. PubMed ID: 10497864
[TBL] [Abstract][Full Text] [Related]
13. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
[TBL] [Abstract][Full Text] [Related]
15. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
von Specht BU; Strigl G; Ehret W; Brendel W
Infection; 1987; 15(5):408-12. PubMed ID: 3121520
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
[TBL] [Abstract][Full Text] [Related]
18. Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.
Yang F; Gu J; Yang L; Gao C; Jing H; Wang Y; Zeng H; Zou Q; Lv F; Zhang J
Sci Rep; 2017 Jun; 7(1):3957. PubMed ID: 28638106
[TBL] [Abstract][Full Text] [Related]
19. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]